🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/03/2022 | 172,83 | 176,00 | 168,67 | 172,48 | -0,21% | 4,24% | 384.700 |
| 07/03/2022 | 173,55 | 175,93 | 171,12 | 172,85 | -0,96% | 2,77% | 364.900 |
| 04/03/2022 | 173,08 | 175,47 | 171,66 | 174,52 | -0,25% | 2,20% | 338.200 |
| 03/03/2022 | 174,53 | 175,49 | 172,77 | 174,96 | -0,22% | 1,56% | 334.700 |
| 02/03/2022 | 166,50 | 176,10 | 166,50 | 175,35 | +5,53% | 5,77% | 587.800 |
| 01/03/2022 | 165,79 | 168,95 | 165,00 | 166,16 | -0,02% | 2,38% | 427.200 |
| 28/02/2022 | 164,75 | 168,90 | 163,19 | 166,20 | -1,07% | 3,47% | 858.200 |
| 25/02/2022 | 166,27 | 170,09 | 166,09 | 168,00 | +0,17% | 2,41% | 713.500 |
| 24/02/2022 | 175,05 | 179,85 | 161,23 | 167,71 | -13,15% | 10,64% | 1.630.200 |
| 23/02/2022 | 195,21 | 195,55 | 191,51 | 193,11 | -0,29% | 2,07% | 344.200 |
| 22/02/2022 | 195,27 | 196,42 | 192,23 | 193,68 | -1,44% | 2,15% | 422.700 |
| 18/02/2022 | 199,22 | 201,00 | 195,83 | 196,50 | -1,71% | 2,60% | 220.000 |
| 17/02/2022 | 204,13 | 204,13 | 199,79 | 199,91 | -2,27% | 2,13% | 577.000 |
| 16/02/2022 | 203,45 | 204,85 | 200,85 | 204,56 | +0,13% | 1,97% | 381.200 |
| 15/02/2022 | 203,02 | 206,97 | 202,48 | 204,29 | +0,71% | 2,21% | 206.000 |
| 14/02/2022 | 203,59 | 206,37 | 201,31 | 202,84 | -0,36% | 2,49% | 371.000 |
| 11/02/2022 | 203,01 | 205,02 | 202,03 | 203,57 | -0,09% | 1,47% | 303.500 |
| 10/02/2022 | 205,06 | 208,63 | 203,08 | 203,75 | -0,58% | 2,71% | 812.300 |
| 09/02/2022 | 199,72 | 205,70 | 199,72 | 204,94 | +2,65% | 2,99% | 314.500 |
| 08/02/2022 | 199,38 | 199,89 | 197,47 | 199,64 | -0,09% | 1,21% | 430.500 |
| 07/02/2022 | 201,59 | 204,51 | 199,44 | 199,81 | -0,88% | 2,52% | 284.900 |
| 04/02/2022 | 198,79 | 203,06 | 197,41 | 201,59 | +1,45% | 2,84% | 197.200 |
| 03/02/2022 | 201,33 | 202,04 | 198,27 | 198,71 | -1,69% | 1,87% | 228.500 |
| 02/02/2022 | 202,12 | 203,13 | 198,69 | 202,12 | -0,42% | 2,20% | 223.700 |
| 01/02/2022 | 201,48 | 204,63 | 200,31 | 202,97 | +0,54% | 2,14% | 388.400 |
| 31/01/2022 | 200,30 | 202,31 | 197,64 | 201,87 | +0,48% | 2,33% | 326.800 |
| 28/01/2022 | 194,93 | 200,94 | 191,85 | 200,90 | +2,94% | 4,66% | 236.200 |
| 27/01/2022 | 198,78 | 200,11 | 193,69 | 195,17 | -1,71% | 3,23% | 311.000 |
| 26/01/2022 | 198,82 | 203,14 | 196,68 | 198,57 | -0,58% | 3,25% | 439.400 |
| 25/01/2022 | 201,16 | 201,70 | 195,92 | 199,72 | -1,20% | 2,87% | 539.700 |